HU9300115D0 - Arabino-furanosyl-purine derivatives and method for producing them - Google Patents
Arabino-furanosyl-purine derivatives and method for producing themInfo
- Publication number
- HU9300115D0 HU9300115D0 HU93115A HU11593A HU9300115D0 HU 9300115 D0 HU9300115 D0 HU 9300115D0 HU 93115 A HU93115 A HU 93115A HU 11593 A HU11593 A HU 11593A HU 9300115 D0 HU9300115 D0 HU 9300115D0
- Authority
- HU
- Hungary
- Prior art keywords
- furanosyl
- arabino
- producing
- purine derivatives
- pharmaceutically acceptable
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 229940083251 peripheral vasodilators purine derivative Drugs 0.000 title 1
- 150000002148 esters Chemical class 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Earth Drilling (AREA)
- Stereophonic System (AREA)
- Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909015914A GB9015914D0 (en) | 1990-07-19 | 1990-07-19 | Heterocyclic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HU9300115D0 true HU9300115D0 (en) | 1993-04-28 |
Family
ID=10679359
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU93115A HU9300115D0 (en) | 1990-07-19 | 1991-07-18 | Arabino-furanosyl-purine derivatives and method for producing them |
| HU93115D HUT62911A (en) | 1990-07-19 | 1991-07-18 | Process for producing arabionofuranosyl pruine derivatives and antitumorous pharmaceutical compositions comprising such compounds as active ingredients |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU93115D HUT62911A (en) | 1990-07-19 | 1991-07-18 | Process for producing arabionofuranosyl pruine derivatives and antitumorous pharmaceutical compositions comprising such compounds as active ingredients |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US5492897A (hu) |
| EP (1) | EP0539479B1 (hu) |
| JP (1) | JP2873086B2 (hu) |
| KR (1) | KR100187326B1 (hu) |
| AT (1) | ATE151637T1 (hu) |
| CA (1) | CA2087543C (hu) |
| CY (1) | CY2165B1 (hu) |
| DE (1) | DE69125715T2 (hu) |
| DK (1) | DK0539479T3 (hu) |
| ES (1) | ES2103311T3 (hu) |
| GB (1) | GB9015914D0 (hu) |
| GR (1) | GR3023776T3 (hu) |
| HU (2) | HU9300115D0 (hu) |
| IE (1) | IE912513A1 (hu) |
| IL (1) | IL98881A (hu) |
| MC (1) | MC2289A1 (hu) |
| MY (1) | MY111871A (hu) |
| NZ (1) | NZ239025A (hu) |
| PT (1) | PT98371B (hu) |
| RU (1) | RU2114860C1 (hu) |
| TW (1) | TW208655B (hu) |
| WO (1) | WO1992001456A1 (hu) |
| ZA (1) | ZA915656B (hu) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9015914D0 (en) * | 1990-07-19 | 1990-09-05 | Wellcome Found | Heterocyclic compounds |
| WO1998042352A1 (en) * | 1997-03-24 | 1998-10-01 | Glaxo Group Ltd. | Method for treating b-cell tumors with ara-g nucleoside derivatives |
| WO2000001388A1 (en) * | 1998-07-02 | 2000-01-13 | Kyowa Hakko Kogyo Co., Ltd. | Remedies for diabetes |
| US6753322B2 (en) * | 2000-06-06 | 2004-06-22 | Pfizer Inc | 2-aminocarbonyl-9H-purine derivatives |
| CN1300165C (zh) * | 2001-11-27 | 2007-02-14 | 安那迪斯药品股份有限公司 | 3-β-呋喃核糖基噻唑并[4,5-d]嘧啶核苷及其应用 |
| US7321033B2 (en) * | 2001-11-27 | 2008-01-22 | Anadys Pharmaceuticals, Inc. | 3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof |
| AU2003261354A1 (en) * | 2002-08-02 | 2004-02-23 | The Regents Of The University Of California | New uses for inhibitors of inosine monophosphate dehydrogenase |
| ATE465742T1 (de) * | 2003-09-05 | 2010-05-15 | Anadys Pharmaceuticals Inc | Tlr7-liganden zur behandlung von hepatitis c |
| GB0321613D0 (en) * | 2003-09-15 | 2003-10-15 | Drug Discovery Lab As | Compounds |
| WO2006030217A2 (en) * | 2004-09-15 | 2006-03-23 | Drug Discovery Laboratory As | Drug conjugates of long chain fatty acid or ester moieties as protein binding prodrugs |
| WO2006053252A2 (en) * | 2004-11-12 | 2006-05-18 | Northwestern University | Methods of treating hematological malignancies with nucleoside analog drugs |
| JP5303149B2 (ja) * | 2004-12-17 | 2013-10-02 | アナディス ファーマシューティカルズ インク | 3,5−二置換及び3,5,7−三置換−3H−オキサゾロ及び3H−チアゾロ[4,5−d]ピリミジン−2−オン化合物及びそのプロドラッグ |
| US20060189543A1 (en) * | 2005-02-23 | 2006-08-24 | Rosenbloom Richard A | Compositions and methods for the treatment of leukemia |
| DE602006015700D1 (de) | 2005-11-21 | 2010-09-02 | Anadys Pharmaceuticals Inc | Neues verfahren zur herstellung von 5-amino-3h-thiazoloä4,5-düpyrimidin-2-on |
| TWI418561B (zh) * | 2006-06-22 | 2013-12-11 | Anadys Pharmaceuticals Inc | 5-胺基-3-(3’-去氧-β-D-核糖呋喃糖基(ribofuranosyl))-噻唑并〔4,5-d〕嘧啶-2,7-二酮之前藥 |
| JP5225991B2 (ja) | 2006-07-18 | 2013-07-03 | アナディス ファーマシューティカルズ インク | チアゾロ[4,5−d]ピリミジンのカーボネート及びカルバメートプロドラッグ |
| CN101768197A (zh) * | 2008-12-29 | 2010-07-07 | 北京德众万全药物技术开发有限公司 | 一种奈拉滨的制备方法 |
| EP2658857B1 (en) | 2010-12-29 | 2016-11-02 | Inhibitex, Inc. | Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections |
| WO2018230479A1 (ja) * | 2017-06-13 | 2018-12-20 | 大原薬品工業株式会社 | ヌクレオシド系抗がん剤又は抗ウィルス剤の5'位シリルエーテル誘導体 |
| CN116874490B (zh) * | 2020-12-30 | 2026-04-14 | 深圳安泰维生物医药有限公司 | 化合物atv014或其药学可接受的盐及其药物组合物 |
| WO2026090323A1 (en) | 2024-10-23 | 2026-04-30 | Incyte Corporation | Combination therapy using a kras g12d inhibitor, and a nucleoside analog, and/or a microtubule inhibitor and its use in the treatment of cancer |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2152486A1 (de) | 1970-11-20 | 1972-06-29 | Akad Wissenschaften Ddr | Verfahren zur Herstellung von 5'-Desoxy-5'-fluor-6-methyl-mercaptopurinribosid |
| US3872084A (en) | 1972-10-10 | 1975-03-18 | Syntex Inc | Purine nucleoside 3,5-cyclicphosphate compounds |
| US4081534A (en) * | 1973-09-11 | 1978-03-28 | Burroughs Wellcome Co. | Amino purine nucleosides as autoimmune suppressant agents |
| GB1573777A (en) * | 1977-11-03 | 1980-08-28 | Wellcome Found | 9-d-arabinonucleosides and an enzymatic process for their preparation |
| JPS61233696A (ja) * | 1985-04-08 | 1986-10-17 | Kanegafuchi Chem Ind Co Ltd | 7−ヒドロキシグアニン誘導体及びその製造方法並びにそれを有効成分とする抗腫瘍剤 |
| JPH0633263B2 (ja) * | 1985-05-27 | 1994-05-02 | 鐘淵化学工業株式会社 | 7−ヒドロキシグアニン誘導体及びその製造方法並びにそれを有効成分とする抗腫瘍剤 |
| GB8712745D0 (en) * | 1987-05-30 | 1987-07-01 | Wellcome Found | Antiviral compounds |
| CA1317291C (en) * | 1987-12-14 | 1993-05-04 | Naeem Botros Hanna | Antitumor 6-sulfenamide, 6-sulfinamide and 6-sulfonamide purines, purine nucleosides, purine nucleotides and related compounds |
| US5352669A (en) * | 1990-03-13 | 1994-10-04 | The Of The United States Of America As Represented By The Department Of Health And Human Services | O6 -benzylated guanine, guanosine and 2'-deoxyguanosine compounds possessing O6 -alkylguanine-DNA alkyltransferase depleting activity |
| GB9015914D0 (en) * | 1990-07-19 | 1990-09-05 | Wellcome Found | Heterocyclic compounds |
-
1990
- 1990-07-19 GB GB909015914A patent/GB9015914D0/en active Pending
-
1991
- 1991-07-18 MC MC91@@D patent/MC2289A1/xx unknown
- 1991-07-18 IE IE251391A patent/IE912513A1/en unknown
- 1991-07-18 JP JP3512249A patent/JP2873086B2/ja not_active Expired - Lifetime
- 1991-07-18 WO PCT/GB1991/001196 patent/WO1992001456A1/en not_active Ceased
- 1991-07-18 HU HU93115A patent/HU9300115D0/hu unknown
- 1991-07-18 KR KR1019930700144A patent/KR100187326B1/ko not_active Expired - Lifetime
- 1991-07-18 ZA ZA915656A patent/ZA915656B/xx unknown
- 1991-07-18 AT AT91913553T patent/ATE151637T1/de not_active IP Right Cessation
- 1991-07-18 EP EP91913553A patent/EP0539479B1/en not_active Expired - Lifetime
- 1991-07-18 DK DK91913553.3T patent/DK0539479T3/da active
- 1991-07-18 ES ES91913553T patent/ES2103311T3/es not_active Expired - Lifetime
- 1991-07-18 MY MYPI91001298A patent/MY111871A/en unknown
- 1991-07-18 NZ NZ239025A patent/NZ239025A/en not_active IP Right Cessation
- 1991-07-18 RU RU93004860A patent/RU2114860C1/ru active Protection Beyond IP Right Term
- 1991-07-18 HU HU93115D patent/HUT62911A/hu unknown
- 1991-07-18 DE DE69125715T patent/DE69125715T2/de not_active Expired - Lifetime
- 1991-07-18 IL IL9888191A patent/IL98881A/en not_active IP Right Cessation
- 1991-07-18 PT PT98371A patent/PT98371B/pt not_active IP Right Cessation
- 1991-07-18 CA CA002087543A patent/CA2087543C/en not_active Expired - Lifetime
- 1991-07-27 TW TW080105920A patent/TW208655B/zh not_active IP Right Cessation
-
1994
- 1994-04-07 US US08/224,343 patent/US5492897A/en not_active Expired - Lifetime
-
1995
- 1995-05-24 US US08/449,078 patent/US5821236A/en not_active Expired - Lifetime
- 1995-05-31 US US08/456,186 patent/US5747472A/en not_active Expired - Lifetime
-
1997
- 1997-06-12 GR GR970401414T patent/GR3023776T3/el unknown
-
2000
- 2000-04-10 CY CY0000009A patent/CY2165B1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUT62911A (en) | 1993-06-28 |
| MY111871A (en) | 2001-02-28 |
| IL98881A (en) | 1996-01-19 |
| CY2165B1 (en) | 2002-08-23 |
| PT98371A (pt) | 1992-06-30 |
| MC2289A1 (fr) | 1993-07-14 |
| EP0539479B1 (en) | 1997-04-16 |
| IE912513A1 (en) | 1992-01-29 |
| AU8196091A (en) | 1992-02-18 |
| GB9015914D0 (en) | 1990-09-05 |
| IL98881A0 (en) | 1992-07-15 |
| DE69125715T2 (de) | 1997-08-07 |
| CA2087543C (en) | 1998-08-25 |
| ATE151637T1 (de) | 1997-05-15 |
| GR3023776T3 (en) | 1997-09-30 |
| US5821236A (en) | 1998-10-13 |
| AU641533B2 (en) | 1993-09-23 |
| CA2087543A1 (en) | 1992-01-20 |
| US5747472A (en) | 1998-05-05 |
| RU2114860C1 (ru) | 1998-07-10 |
| US5492897A (en) | 1996-02-20 |
| NZ239025A (en) | 1993-08-26 |
| EP0539479A1 (en) | 1993-05-05 |
| PT98371B (pt) | 1999-01-29 |
| WO1992001456A1 (en) | 1992-02-06 |
| JPH05508649A (ja) | 1993-12-02 |
| KR100187326B1 (ko) | 1999-05-01 |
| TW208655B (hu) | 1993-07-01 |
| ZA915656B (en) | 1993-03-31 |
| ES2103311T3 (es) | 1997-09-16 |
| JP2873086B2 (ja) | 1999-03-24 |
| DE69125715D1 (de) | 1997-05-22 |
| DK0539479T3 (da) | 1997-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2165B1 (en) | Heterocyclic compounds | |
| AU5367290A (en) | Pharmaceutical compositions | |
| ES8801303A1 (es) | Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido. | |
| EP0337256A3 (de) | Verfahren zur Herstellung pharmazeutischer Mischungen | |
| AU5061190A (en) | Novel benzimidazole and azabenzimidazole derivatives, their methods of preparation, synthesis intermediates and pharmaceutical compositions in which they are present and which are useful especially for the treatment of cardiovascular diseases and duodenal ulcers | |
| UA32512C2 (uk) | Похідні ксантину, спосіб їх одержання, та фармацевтична композиція | |
| BG103647A (en) | Cisplatina containing microgranules | |
| EP0729748A4 (en) | METHOD FOR PRODUCING STABLE MEDICINAL PRODUCTS AND PHARMACEUTICAL PREPARATION | |
| NO305557B1 (no) | Amfifiliske imidazoliniumderivater og fremgangsmÕte for fremstilling av imidazoliniumion | |
| IL112957A0 (en) | Thieno [2,3-b] indoles, their preparation and pharmaceutical compositions containing them | |
| HUT48269A (en) | Process for producing pharmaceutically active nukleozide and pharmaceutical compositions containing them | |
| RU93004860A (ru) | Гетероциклические соединения, способ их получения, использование и фармацевтическая композиция | |
| MX9800407A (es) | Nuevos derivados de galantamina, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contiene. | |
| AU2923389A (en) | A pharmaceutical composition | |
| HUT49598A (en) | Process for producing chromone derivatives and pharmaceutical compositions comprising same as active ingredient | |
| TW374085B (en) | Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use | |
| HU9201358D0 (en) | 2-amino-pirimidine-4-carboxamide derivatives, process for their production and for the production of medical preparations containing them as active agents | |
| GR3034886T3 (en) | Substituted benzenesulfonylureas and -thioureas, process for their preparation and their use in the production of pharmaceutical preparations as well as pharmaceutical preparations containing them | |
| CA2188297A1 (en) | Lactone stable formulation of camptothecin or 7-ethyl camptothecin | |
| HUT64548A (en) | Method for producing new phosphocipid derivatives and pharmaceutical preparatives containing them | |
| HRP960081B1 (en) | Substituted benzenesulfonylureas and -thioureas, process for their preparation, their use in the production of pharmaceutical preparations and medicaments containing them | |
| ZA91901B (en) | Side-chain homologous vitamin d derivatives,process for their production,pharmaceutical preparations containing these derivatives and their use as pharmaceutical agents | |
| JO2296B1 (en) | Substituted pyrolates | |
| HUT50807A (en) | Process for producing pharmaceutical compositions comprising labdane derivatives as active ingredient and for producing the active ingredient | |
| MX9705959A (es) | Formulaciones para il-12. |